![]() |
|
|
Department of Physiology, University of Queensland, St. Lucia, Queensland 4067, Australia
The adrenergic control of hypertension in choline deficiency has been studied by the use of
-methyl dopa (
MD). The development of hypertension in male, weanling rats fed a choline-deficient diet was prevented by the
MD without interference to the growth rate of the rats, by providing it at 50 mg/100 g food. At this level,
MD did not have any effects on either liver weight or liver lipid content of the choline-deficient rats.
MD had no measurable effects on choline-supplemented rats. The present results contrast with earlier work with ethyl trichloracetate which lowers hypertension and prevents excess liver lipid accumulation in choline deficiency. It is postulated that
MD acts as a hypotensive agent through being an adrenergic blocking agent.
Manuscript received 29 December 1969.